TOP TIERMARKET NEWSWIRE
News & sentiment

CRISPR THERAPEUTICS (CRSP) — News & AI sentiment

CRISPR THERAPEUTICS (CRSP) news roundup. 8 stories in the past week, 21 over 30 days. Average 30-day sentiment is 59/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
8
avg sentiment 60.9/100
30d stories
21
avg sentiment 59/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

CRSP news in the last 24 hours, 7 days, 30 days and 90 days

How much CRSP coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowCRSP storiesAvg AI sentimentRead
Last 24 hours0no coverage
Last 7 days860.9/100CRSP headlines →
Last 30 days2159/100CRSP headlines →
Last 90 days4861.2/100CRSP headlines →

Latest stories on CRSP

2d ago
2d ago
5d ago
5d ago
5d ago
Where Will CRISPR Therapeutics Stock Be in 5 Years?
The Motley Fool67 · bullishgeneral
5d ago
5d ago
6d ago
Sep 5
Sep 2
Sep 2
Sep 1
H.C. Wainwright reiterates CRISPR Therapeutics stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Aug 31
Citizens reiterates CRISPR Therapeutics stock rating on gene therapy data
Investing.com Analyst Ratings56 · neutralanalyst
Aug 31
Aug 31
Aug 28
Aug 28
Aug 28
Aug 28
Citizens reaffirms CRISPR Therapeutics stock rating on gene therapy data
Investing.com Analyst Ratings56 · neutralanalyst
Aug 25
Aug 21
Aug 7
Aug 6
Aug 6
Aug 5
Open CRSP in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →